Maravai Lifesciences Holdings Inc (MRVI) — Cash Flow Quality Index

Latest as of December 2022: 1.14x

Maravai Lifesciences Holdings Inc (MRVI) has a Cash Flow Quality Index of 1.14x as of December 2022. Operating cash flow of $99.33 Million exceeds net income of $87.43 Million, indicating high earnings quality where cash backs reported profits. Also explore Maravai Lifesciences Holdings Inc balance sheet assets for the complete picture of this company's asset base.

Cash Flow Quality Index

1.14x
Operating CF / Net Income

Operating Cash Flow

$99.33 Million
USD

Net Income

$87.43 Million
USD

Data as of

Dec 2022
Most recent filing

Maravai Lifesciences Holdings Inc Cash Flow Quality Index (2020–2022)

Historical Cash Flow Quality Index for Maravai Lifesciences Holdings Inc across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check MRVI tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Annual Cash Flow Quality Index for Maravai Lifesciences Holdings Inc (2020–2022)

Year-by-year earnings quality comparison for Maravai Lifesciences Holdings Inc. For live market cap and the full company financial profile, see market value of Maravai Lifesciences Holdings Inc.

Year Quality Index Operating CF (USD) Net Income YoY Change
2022 1.09x $535.98 Million $490.66 Million ▲ +39.1%
2021 0.79x $368.57 Million $469.25 Million ▼ -59.3%
2020 1.93x $152.19 Million $78.82 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.